Study reveals differing attitudes to PGD among

Ms Mandy Katz told the European Society of Human Reproduction and Embryology annual meeting in Lausanne today (Wednesday 4 July) that these attitudes included quite different views on the status of embryos versus a fetus, limitations regarding what disorders should be treated and who should be able to access preimplantation genetic diagnosis (PGD)* technology, the availability of IVF technology for fertile couples and the possibility in the future of being able to select for other favourable genetic traits.

Ms Katz, a PhD student, and her colleagues at the Monash Institute of Reproduction and Development in Australia, asked questions of couples who were seeking treatment for PGD for single gene disorders that could be passed on to their children (group A), couples who were seeking treatment for PGD to avoid having children born with chromosomal abnormalities such as Downs Syndrome (group B), and infertile couples who were presenting for their first cycle of IVF for general infertility problems and who were not having PGD (control group).

The study found that less than 5% of the couples from groups A and B disagreed with the statement that it was less wrong to destroy an embryo prior to implantation than it was to destroy a fetus during pregnancy, in comparison to 25% of couples in the control group. Ms Katz said: "PGD couples know that only a proportion of their embryos are normal and therefore they considered the destruction of abnormal embryos to be more acceptable. On the other hand, the patients undergoing their first IVF cycle considered every embryo to be potentially normal since every embryo to them is regarded as a potential baby."

When asked whether the couples, if given a choice, would accept the transfer of an embryo identified as being an asymptomatic carrier of the disease, two thirds of group A couples (who themselves are carriers) said "yes", compared with only a minority of the couples from group B and the control group

Contact: Margaret Willson
European Society for Human Reproduction and Embryology

Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:

(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. today announced a ... Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of ... a highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. While the ... economic downturn will only increase price pressures overall for the industry. The era of ... every product launch is critical. However, history shows that only a third of product ...
(Date:7/2/2020)... , ... July 01, 2020 , ... ... its phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory ... 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a ... has closed on the purchase of greenfield for a new, expanded manufacturing facility. ... over 21 acres in the initial acquisition, with an option to purchase an ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has introduced ... materials for use with CRM, neurostimulation, vascular, and related devices. , Anomet ... design requirements, performance, and cost criteria; especially where solid wire is limited. Typical ...
(Date:7/31/2020)... ... , ... The SDX® Respiratory Gating System , trusted ... its 20th anniversary of worldwide use. Introduced in the US over the past ... of Pennsylvania, University of Michigan, University of Maryland, University of California San Francisco—and ...
Breaking Biology Technology:
Cached News: